|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
Statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mattick JS and Makunin IV: Non-coding RNA.
Hum Mol Genet 15 Spec No. 1:R17–R29. 2006. View Article : Google Scholar
|
|
5
|
Bonasio R and Shiekhattar R: Regulation of
transcription by long noncoding RNAs. Annu Rev Genet. 48:433–455.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Eddy SR: Non-coding RNA genes and the
modern RNA world. Nat Rev Genet. 2:919–929. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Guttman M and Rinn JL: Modular regulatory
principles of large non-coding RNAs. Nature. 482:339–346. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Batista PJ and Chang HY: Long noncoding
RNAs: Cellular address codes in development and disease. Cell.
152:1298–1307. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
St Laurent G, Wahlestedt C and Kapranov P:
The Landscape of long noncoding RNA classification. Trends Genet.
31:239–251. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gupta RA, Shah N, Wang KC, Kim J, Horlings
HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, et al: Long
non-coding RNA HOTAIR reprograms chromatin state to promote cancer
metastasis. Nature. 464:1071–1076. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yildirim E, Kirby JE, Brown DE, Mercier
FE, Sadreyev RI, Scadden DT and Lee JT: Xist RNA is a potent
suppressor of hematologic cancer in mice. Cell. 152:727–742. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hung T, Wang Y, Lin MF, Koegel AK, Kotake
Y, Grant GD, Horlings HM, Shah N, Umbricht C, Wang P, et al:
Extensive and coordinated transcription of noncoding RNAs within
cell-cycle promoters. Nat Genet. 43:621–629. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Guttman M, Donaghey J, Carey BW, Garber M,
Grenier JK, Munson G, Young G, Lucas AB, Ach R, Bruhn L, et al:
lincRNAs act in the circuitry controlling pluripotency and
differentiation. Nature. 477:295–300. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gomez JA, Wapinski OL, Yang YW, Bureau JF,
Gopinath S, Monack DM, Chang HY, Brahic M and Kirkegaard K: The
NeST long ncRNA controls microbial susceptibility and epigenetic
activation of the interferon-γ locus. Cell. 152:743–754. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huarte M, Guttman M, Feldser D, Garber M,
Koziol MJ, Kenzelmann-Broz D, Khalil AM, Zuk O, Amit I, Rabani M,
et al: A large intergenic noncoding RNA induced by p53 mediates
global gene repression in the p53 response. Cell. 142:409–419.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wilusz JE, Sunwoo H and Spector DL: Long
noncoding RNAs: Functional surprises from the RNA world. Genes Dev.
23:1494–1504. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Engreitz JM, Pandya-Jones A, McDonel P,
Shishkin A, Sirokman K, Surka C, Kadri S, Xing J, Goren A, Lander
ES, et al: The Xist lncRNA exploits three-dimensional genome
architecture to spread across the X chromosome. Science.
341:12379732013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li W, Notani D, Ma Q, Tanasa B, Nunez E,
Chen AY, Merkurjev D, Zhang J, Ohgi K, Song X, et al: Functional
roles of enhancer RNAs for oestrogen-dependent transcriptional
activation. Nature. 498:516–520. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ørom UA, Derrien T, Beringer M, Gumireddy
K, Gardini A, Bussotti G, Lai F, Zytnicki M, Notredame C, Huang Q,
et al: Long noncoding RNAs with enhancer-like function in human
cells. Cell. 143:46–58. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Di Ruscio A, Ebralidze AK, Benoukraf T,
Amabile G, Goff LA, Terragni J, Figueroa ME, De Figueiredo Pontes
LL, Alberich-Jorda M, Zhang P, et al: DNMT1-interacting RNAs block
gene-specific DNA methylation. Nature. 503:371–376. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hansen TB, Jensen TI, Clausen BH, Bramsen
JB, Finsen B, Damgaard CK and Kjems J: Natural RNA circles function
as efficient microRNA sponges. Nature. 495:384–388. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nissan A, Stojadinovic A,
Mitrani-Rosenbaum S, Halle D, Grinbaum R, Roistacher M, Bochem A,
Dayanc BE, Ritter G, Gomceli I, et al: Colon cancer associated
transcript-1: A novel RNA expressed in malignant and pre-malignant
human tissues. Int J Cancer. 130:1598–1606. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xiang JF, Yin QF, Chen T, Zhang Y, Zhang
XO, Wu Z, Zhang S, Wang HB, Ge J, Lu X, et al: Human colorectal
cancer-specific CCAT1-L lncRNA regulates long-range chromatin
interactions at the MYC locus. Cell Res. 24:513–531. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wu Y, Tan C, Weng WW, Deng Y, Zhang QY,
Yang XQ, Gan HL, Wang T, Zhang PP, Xu MD, et al: Long non-coding
RNA Linc00152 is a positive prognostic factor for and demonstrates
malignant biological behavior in clear cell renal cell carcinoma.
Am J Cancer Res. 6:285–299. 2016.PubMed/NCBI
|
|
25
|
Deng L, Yang SB, Xu FF and Zhang JH: Long
noncoding RNA CCAT1 promotes hepatocellular carcinoma progression
by functioning as let-7 sponge. J Exp Clin Cancer Res. 34:182015.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang H, Zhong J, Bian Z, Fang X, Peng Y
and Hu Y: Long non-coding RNA CCAT1 promotes human retinoblastoma
SO-RB50 and Y79 cells through negative regulation of miR-218-5p.
Biomed Pharmacother. 87:683–691. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zanke BW, Greenwood CM, Rangrej J, Kustra
R, Tenesa A, Farrington SM, Prendergast J, Olschwang S, Chiang T,
Crowdy E, et al: Genome-wide association scan identifies a
colorectal cancer susceptibility locus on chromosome 8q24. Nat
Genet. 39:989–994. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yeager M, Orr N, Hayes RB, Jacobs KB,
Kraft P, Wacholder S, Minichiello MJ, Fearnhead P, Yu K, Chatterjee
N, et al: Genome-wide association study of prostate cancer
identifies a second risk locus at 8q24. Nat Genet. 39:645–649.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Younger ST and Rinn JL: ‘Lnc’-ing
enhancers to MYC regulation. Cell Res. 24:643–644. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
He X, Tan X, Wang X, Jin H, Liu L, Ma L,
Yu H and Fan Z: C-Myc-activated long noncoding RNA CCAT1 promotes
colon cancer cell proliferation and invasion. Tumour Biol.
35:12181–12188. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhuang K, Wu Q, Jiang S, Yuan H, Huang S
and Li H: CCAT1 promotes laryngeal squamous cell carcinoma cell
proliferation and invasion. Am J Transl Res. 8:4338–4345.
2016.PubMed/NCBI
|
|
32
|
Siegel RL, Miller KD, Fedewa SA, Ahnen DJ,
Meester RG, Barzi A and Jemal A: Colorectal cancer statistics,
2017. CA Cancer J Clin. 67:177–193. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kogo R, Shimamura T, Mimori K, Kawahara K,
Imoto S, Sudo T, Tanaka F, Shibata K, Suzuki A, Komune S, et al:
Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin
modification and is associated with poor prognosis in colorectal
cancers. Cancer Res. 71:6320–6326. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ling H, Spizzo R, Atlasi Y, Nicoloso M,
Shimizu M, Redis RS, Nishida N, Gafà R, Song J, Guo Z, et al:
CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic
progression and chromosomal instability in colon cancer. Genome
Res. 23:1446–1461. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zheng HT, Shi DB, Wang YW, Li XX, Xu Y,
Tripathi P, Gu WL, Cai GX and Cai SJ: High expression of lncRNA
MALAT1 suggests a biomarker of poor prognosis in colorectal cancer.
Int J Clin Exp Pathol. 7:3174–3181. 2014.PubMed/NCBI
|
|
36
|
Wang X, Yang Z, Tian H, Li Y, Li M, Zhao
W, Zhang C, Wang T, Liu J, Zhang A, et al: Circulating MIC-1/GDF15
is a complementary screening biomarker with CEA and correlates with
liver metastasis and poor survival in colorectal cancer.
Oncotarget. 8:24892–24901. 2017.PubMed/NCBI
|
|
37
|
Yue B, Cai D, Liu C, Fang C and Yan D:
linc00152 functions as a competing endogenous RNA to confer
oxaliplatin resistance and holds prognostic values in colon cancer.
Mol Ther. 24:2064–2077. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Luo J, Qu J, Wu DK, Lu ZL, Sun YS and Qu
Q: Long non-coding RNAs: A rising biotarget in colorectal cancer.
Oncotarget. 8:22187–22202. 2017.PubMed/NCBI
|
|
39
|
Fang L, Lu W, Choi HH, Yeung SC, Tung JY,
Hsiao CD, Fuentes-Mattei E, Menter D, Chen C, Wang L, et al:
ERK2-dependent phosphorylation of CSN6 is critical in colorectal
cancer development. Cancer Cell. 28:183–197. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Jing F, Jin H, Mao Y, Li Y, Ding Y, Fan C
and Chen K: Genome-wide analysis of long non-coding RNA expression
and function in colorectal cancer. Tumour Biol.
39:10104283177036502017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Alaiyan B, Ilyayev N, Stojadinovic A,
Izadjoo M, Roistacher M, Pavlov V, Tzivin V, Halle D, Pan H, Trink
B, et al: Differential expression of colon cancer associated
transcript1 (CCAT1) along the colonic adenoma-carcinoma sequence.
BMC Cancer. 13:1962013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kim T, Cui R, Jeon YJ, Lee JH, Lee JH, Sim
H, Park JK, Fadda P, Tili E, Nakanishi H, et al: Long-range
interaction and correlation between MYC enhancer and oncogenic long
noncoding RNA CARLo-5. Proc Natl Acad Sci USA. 111:4173–4178. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ye Z, Zhou M, Tian B, Wu B and Li J:
Expression of lncRNA-CCAT1, E-cadherin and N-cadherin in colorectal
cancer and its clinical significance. Int J Clin Exp Med.
8:3707–3715. 2015.PubMed/NCBI
|
|
44
|
Ozawa T, Matsuyama T, Toiyama Y, Takahashi
N, Ishikawa T, Uetake H, Yamada Y, Kusunoki M, Calin G and Goel A:
CCAT1 and CCAT2 long noncoding RNAs, located within the 8q.24.21
‘gene desert’, serve as important prognostic biomarkers in
colorectal cancer. Ann Oncol. 28:1882–1888. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhao W, Song M, Zhang J, Kuerban M and
Wang H: Combined identification of long non-coding RNA CCAT1 and
HOTAIR in serum as an effective screening for colorectal carcinoma.
Int J Clin Exp Pathol. 8:14131–14140. 2015.PubMed/NCBI
|
|
46
|
Kam Y, Rubinstein A, Naik S, Djavsarov I,
Halle D, Ariel I, Gure AO, Stojadinovic A, Pan H, Tsivin V, et al:
Detection of a long non-coding RNA (CCAT1) in living cells and
human adenocarcinoma of colon tissues using FIT-PNA molecular
beacons. Cancer Lett. 352:90–96. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Shi J and Vakoc CR: The mechanisms behind
the therapeutic activity of BET bromodomain inhibition. Mol Cell.
54:728–736. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
McCleland ML, Mesh K, Lorenzana E, Chopra
VS, Segal E, Watanabe C, Haley B, Mayba O, Yaylaoglu M, Gnad F and
Firestein R: CCAT1 is an enhancer-templated RNA that predicts BET
sensitivity in colorectal cancer. J Clin Invest. 126:639–652. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Ren J, Zhu D, Liu M, Sun Y and Tian L:
Downregulation of miR-21 modulates Ras expression to promote
apoptosis and suppress invasion of Laryngeal squamous cell
carcinoma. Eur J Cancer. 46:3409–3416. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Chu EA and Kim YJ: Laryngeal cancer:
Diagnosis and preoperative work-up. Otolaryngol Clin North Am.
41:673–695. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Wang W, Lin P, Han C, Cai W, Zhao X and
Sun B: Vasculogenic mimicry contributes to lymph node metastasis of
laryngeal squamous cell carcinoma. J Exp Clin Cancer Res.
29:602010. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Zhang Y and Hu H: Long non-coding RNA
CCAT1/miR-218/ZFX axis modulates the progression of laryngeal
squamous cell cancer. Tumour Biol.
39:10104283176994172017.PubMed/NCBI
|
|
53
|
Matsushima K, Isomoto H, Yamaguchi N,
Inoue N, Machida H, Nakayama T, Hayashi T, Kunizaki M, Hidaka S,
Nagayasu T, et al: MiRNA-205 modulates cellular invasion and
migration via regulating zinc finger E-box binding homeobox 2
expression in esophageal squamous cell carcinoma cells. J Transl
Med. 9:302011. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Enzinger PC and Mayer RJ: Esophageal
cancer. N Engl J Med. 349:2241–2252. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Zhang E, Han L, Yin D, He X, Hong L, Si X,
Qiu M, Xu T, De W, Xu L, et al: H3K27 acetylation activated-long
non-coding RNA CCAT1 affects cell proliferation and migration by
regulating SPRY4 and HOXB13 expression in esophageal squamous cell
carcinoma. Nucleic Acids Res. 45:3086–3101. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Zhang Y, Ma M, Liu W, Ding W and Yu H:
Enhanced expression of long noncoding RNA CARLo-5 is associated
with the development of gastric cancer. Int J Clin Exp Pathol.
7:8471–8479. 2014.PubMed/NCBI
|
|
57
|
Mizrahi I, Mazeh H, Grinbaum R, Beglaibter
N, Wilschanski M, Pavlov V, Adileh M, Stojadinovic A, Avital I,
Gure AO, et al: Colon cancer associated transcript-1 (CCAT1)
expression in adenocarcinoma of the stomach. J Cancer. 6:105–110.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Yang F, Xue X, Bi J, Zheng L, Zhi K, Gu Y
and Fang G: Long noncoding RNA CCAT1, which could be activated by
c-Myc, promotes the progression of gastric carcinoma. J Cancer Res
Clin Oncol. 139:437–445. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Zhou B, Wang Y, Jiang J, Jiang H, Song J,
Han T, Shi J and Qiao H: The long noncoding RNA colon
cancer-associated transcript-1/miR-490 axis regulates gastric
cancer cell migration by targeting hnRNPA1. IUBMB Life. 68:201–210.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Liu JN and Shangguan YM: Long non-coding
RNA CARLo-5 upregulation associates with poor prognosis in patients
suffering gastric cancer. Eur Rev Med Pharmacol Sci. 21:530–534.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Pino I, Pio R, Toledo G, Zabalegui N,
Vicent S, Rey N, Lozano MD, Torre W, Garcia-Foncillas J and
Montuenga LM: Altered patterns of expression of members of the
heterogeneous nuclear ribonucleoprotein (hnRNP) family in lung
cancer. Lung Cancer. 41:131–143. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Buvoli M, Cobianchi F, Biamonti G and Riva
S: Recombinant hnRNP protein A1 and its N-terminal domain show
preferential affinity for oligodeoxynucleotides homologous to
intron/exon acceptor sites. Nucleic Acids Res. 18:6595–6600. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Carpenter B, MacKay C, Alnabulsi A, MacKay
M, Telfer C, Melvin WT and Murray GI: The roles of heterogeneous
nuclear ribonucleoproteins in tumour development and progression.
Biochim Biophys Acta. 1765:85–100. 2006.PubMed/NCBI
|
|
64
|
Boukakis G, Patrinou-Georgoula M,
Lekarakou M, Valavanis C and Guialis A: Deregulated expression of
hnRNP A/B proteins in human non-small cell lung cancer: Parallel
assessment of protein and mRNA levels in paired tumour/non-tumour
tissues. BMC Cancer. 10:4342010. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
David CJ, Chen M, Assanah M, Canoll P and
Manley JL: HnRNP proteins controlled by c-Myc deregulate pyruvate
kinase mRNA splicing in cancer. Nature. 463:364–368. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Yang JD and Roberts LR: Hepatocellular
carcinoma: A global view. Nat Rev Gastroenterol Hepatol. 7:448–458.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Wang F, Xie C, Zhao W, Deng Z, Yang H and
Fang Q: Long non-coding RNA CARLo-5 expression is associated with
disease progression and predicts outcome in hepatocellular
carcinoma patients. Clin Exp Med. 17:33–43. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Zhu H, Zhou X, Chang H, Li H, Liu F, Ma C
and Lu J: CCAT1 promotes hepatocellular carcinoma cell
proliferation and invasion. Int J Clin Exp Pathol. 8:5427–5434.
2015.PubMed/NCBI
|
|
70
|
Zhu HQ, Zhou X, Chang H, Li HG, Liu FF, Ma
CQ and Lu J: Aberrant expression of CCAT1 regulated by c-Myc
predicts the prognosis of hepatocellular carcinoma. Asian Pac J
Cancer Prev. 16:5181–5185. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Dou C, Sun L, Jin X, Han M, Zhang B, Jiang
X, Lv J and Li T: Long non-coding RNA CARLo-5 promotes tumor
progression in hepatocellular carcinoma via suppressing miR-200b
expression. Oncotarget. 8:70172–70182. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Dou C, Sun L, Jin X, Han M, Zhang B and Li
T: Long non-coding RNA colon cancer-associated transcript 1
functions as a competing endogenous RNA to regulate
cyclin-dependent kinase 1 expression by sponging miR-490-3p in
hepatocellular carcinoma progression. Tumour Biol.
39:10104283176975722017. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Zhu AX, Hong TS, Hezel AF and Kooby DA:
Current management of gallbladder carcinoma. Oncologist.
15:168–181. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Jiao Y, Pawlik TM, Anders RA, Selaru FM,
Streppel MM, Lucas DJ, Niknafs N, Guthrie VB, Maitra A, Argani P,
et al: Exome sequencing identifies frequent inactivating mutations
in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas. Nat
Genet. 45:1470–1473. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Ma MZ, Chu BF, Zhang Y, Weng MZ, Qin YY,
Gong W and Quan ZW: Long non-coding RNA CCAT1 promotes gallbladder
cancer development via negative modulation of miRNA-218-5p. Cell
Death Dis. 6:e15832015. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Khan SA, Thomas HC, Davidson BR and
Taylor-Robinson SD: Cholangiocarcinoma. Lancet. 366:1303–1314.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Jiang XM, Li ZL, Li JL, Zheng WY, Li XH,
Cui YF and Sun DJ: LncRNA CCAT1 as the unfavorable prognostic
biomarker for cholangiocarcinoma. Eur Rev Med Pharmacol Sci.
21:1242–1247. 2017.PubMed/NCBI
|
|
78
|
Zhang S, Xiao J, Chai Y, Du YY, Liu Z,
Huang K, Zhou X and Zhou W: LncRNA-CCAT1 promotes migration,
invasion, and EMT in intrahepatic cholangiocarcinoma through
suppressing miR-152. Dig Dis Sci. 62:3050–3058. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Li C, Heidt DG, Dalerba P, Burant CF,
Zhang L, Adsay V, Wicha M, Clarke MF and Simeone DM: Identification
of pancreatic cancer stem cells. Cancer Res. 67:1030–1037. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Von Hoff DD, Ervin T, Arena FP, Chiorean
EG, Infante J, Moore M, Seay T, Tjulandin SA, Ma WW, Saleh MN, et
al: Increased survival in pancreatic cancer with nab-paclitaxel
plus gemcitabine. N Engl J Med. 369:1691–1703. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Yu Q, Zhou X, Xia Q, Shen J, Yan J, Zhu J,
Li X and Shu M: Long non-coding RNA CCAT1 that can be activated by
c-Myc promotes pancreatic cancer cell proliferation and migration.
Am J Transl Res. 8:5444–5454. 2016.PubMed/NCBI
|
|
82
|
Bartek J and Lukas J: DNA repair: Cyclin
D1 multitasks. Nature. 474:171–172. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Bray F, Jemal A, Grey N, Ferlay J and
Forman D: Global cancer transitions according to the Human
Development Index (2008–2030): A population-based study. Lancet
Oncol. 13:790–801. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Roth A and Diederichs S: Long noncoding
RNAs in lung cancer. Curr Top Microbiol Immunol. 394:57–110.
2016.PubMed/NCBI
|
|
86
|
White NM, Cabanski CR, Silva-Fisher JM,
Dang HX, Govindan R and Maher CA: Transcriptome sequencing reveals
altered long intergenic non-coding RNAs in lung cancer. Genome
Biol. 15:4292014. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Luo J, Tang L, Zhang J, Ni J, Zhang HP,
Zhang L, Xu JF and Zheng D: Long non-coding RNA CARLo-5 is a
negative prognostic factor and exhibits tumor pro-oncogenic
activity in non-small cell lung cancer. Tumour Biol.
35:11541–11549. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Cabanski CR, White NM, Dang HX,
Silva-Fisher JM, Rauck CE, Cicka D and Maher CA: Pan-cancer
transcriptome analysis reveals long noncoding RNAs with conserved
function. RNA Biol. 12:628–642. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Hu B, Zhang H, Wang Z, Zhang F, Wei H and
Li L: LncRNA CCAT1/miR-130a-3p axis increases cisplatin resistance
in non-small-cell lung cancer cell line by targeting SOX4. Cancer
Biol Ther. 18:974–983. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Lu L, Xu H, Luo F, Liu X, Lu X, Yang Q,
Xue J, Chen C, Shi L and Liu Q: Epigenetic silencing of miR-218 by
the lncRNA CCAT1, acting via BMI1, promotes an altered cell cycle
transition in the malignant transformation of HBE cells induced by
cigarette smoke extract. Toxicol Appl Pharmacol. 304:30–41. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Lu L, Qi H, Luo F, Xu H, Ling M, Qin Y,
Yang P, Liu X, Yang Q, Xue J, et al: Feedback circuitry via let-7c
between lncRNA CCAT1 and c-Myc is involved in cigarette smoke
extract-induced malignant transformation of HBE cells. Oncotarget.
8:19285–19297. 2017.PubMed/NCBI
|
|
92
|
Chen J, Zhang K, Song H, Wang R, Chu X and
Chen L: Long noncoding RNA CCAT1 acts as an oncogene and promotes
chemoresistance in docetaxel-resistant lung adenocarcinoma cells.
Oncotarget. 7:62474–62489. 2016.PubMed/NCBI
|
|
93
|
Cao Y, Shi H, Ren F, Jia Y and Zhang R:
Long non-coding RNA CCAT1 promotes metastasis and poor prognosis in
epithelial ovarian cancer. Exp Cell Res. 359:185–194. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Liu SP, Yang JX, Cao DY and Shen K:
Identification of differentially expressed long non-coding RNAs in
human ovarian cancer cells with different metastatic potentials.
Cancer Biol Med. 10:138–141. 2013.PubMed/NCBI
|
|
95
|
DeSantis C, Ma J, Bryan L and Jemal A:
Breast cancer statistics, 2013. CA Cancer J Clin. 64:52–62. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Zhang XF, Liu T, Li Y and Li S:
Overexpression of long non-coding RNA CCAT1 is a novel biomarker of
poor prognosis in patients with breast cancer. Int J Clin Exp
Pathol. 8:9440–9445. 2015.PubMed/NCBI
|
|
97
|
Lai Y, Chen Y, Lin Y and Ye L:
Down-regulation of LncRNA CCAT1 enhances radiosensitivity via
regulating miR-148b in breast cancer. Cell Biol Int. 42:227–236.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Jia L, Zhang Y, Tian F, Chu Z and Xin H:
Long noncoding RNA colon cancer associated transcript-1 promotes
the proliferation, migration and invasion of cervical cancer. Mol
Med Rep. 16:5587–5591. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Zhao X, Wei X, Zhao L, Shi L, Cheng J,
Kang S, Zhang H, Zhang J, Li L, Zhang H and Zhao W: The rs6983267
SNP and long non-coding RNA CARLo-5 are associated with endometrial
carcinoma. Environ Mol Mutagen. 57:508–515. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Ma X, Sheng S, Wu J, Jiang Y, Gao X, Cen
X, Wu J, Wang S, Tang Y, Tang Y and Liang X: LncRNAs as an
intermediate in HPV16 promoting myeloid-derived suppressor cell
recruitment of head and neck squamous cell carcinoma. Oncotarget.
8:42061–42075. 2017.PubMed/NCBI
|
|
101
|
Gao R, Zhang R, Zhang C, Zhao L and Zhang
Y: Long noncoding RNA CCAT1 promotes cell proliferation and
metastasis in human medulloblastoma via MAPK pathway. Tumori.
104:43–50. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Chen L, Wang W, Cao L, Li Z and Wang X:
Long non-coding RNA CCAT1 acts as a competing endogenous RNA to
regulate cell growth and differentiation in acute myeloid leukemia.
Mol Cell. 39:330–336. 2016. View Article : Google Scholar
|
|
103
|
Zhao J and Cheng L: Long non-coding RNA
CCAT1/miR-148a axis promotes osteosarcoma proliferation and
migration through regulating PIK3IP1. Acta Biochim Biophys Sin
(Shanghai). 49:503–512. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Wang Q, Zhang W and Hao S: LncRNA CCAT1
modulates the sensitivity of paclitaxel in nasopharynx cancers
cells via miR-181a/CPEB2 axis. Cell Cycle. 16:795–801. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Lv L, Jia JQ and Chen J: LncRNA CCAT1
Upregulates Proliferation and Invasion in Melanoma Cells Via
Suppressing miR-33a. Oncol Res. 26:201–208. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Wang ZH, Guo XQ, Zhang QS, Zhang JL, Duan
YL, Li GF and Zheng DL: Long non-coding RNA CCAT1 promotes glioma
cell proliferation via inhibiting microRNA-410. Biochem Biophys Res
Commun. 480:715–720. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Cui B, Li B, Liu Q and Cui Y: lncRNA CCAT1
promotes glioma tumorigenesis by sponging miR-181b. J Cell Biochem.
118:4548–4557. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Gabrilovich DI and Nagaraj S:
Myeloid-derived suppressor cells as regulators of the immune
system. Nat Rev Immunol. 9:162–174. 2009. View Article : Google Scholar : PubMed/NCBI
|
